rs1052571

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001229.5(CASP9):​c.83C>T​(p.Ala28Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.536 in 1,537,426 control chromosomes in the GnomAD database, including 223,949 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A28T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.59 ( 26741 hom., cov: 32)
Exomes 𝑓: 0.53 ( 197208 hom. )

Consequence

CASP9
NM_001229.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.25

Publications

64 publications found
Variant links:
Genes affected
CASP9 (HGNC:1511): (caspase 9) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.70045E-6).
BP6
Variant 1-15524118-G-A is Benign according to our data. Variant chr1-15524118-G-A is described in ClinVar as Benign. ClinVar VariationId is 1275295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.698 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASP9NM_001229.5 linkc.83C>T p.Ala28Val missense_variant Exon 1 of 9 ENST00000333868.10 NP_001220.2 P55211-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASP9ENST00000333868.10 linkc.83C>T p.Ala28Val missense_variant Exon 1 of 9 1 NM_001229.5 ENSP00000330237.5 P55211-1

Frequencies

GnomAD3 genomes
AF:
0.586
AC:
88922
AN:
151748
Hom.:
26703
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.704
Gnomad AMI
AF:
0.514
Gnomad AMR
AF:
0.499
Gnomad ASJ
AF:
0.493
Gnomad EAS
AF:
0.646
Gnomad SAS
AF:
0.426
Gnomad FIN
AF:
0.651
Gnomad MID
AF:
0.509
Gnomad NFE
AF:
0.538
Gnomad OTH
AF:
0.555
GnomAD2 exomes
AF:
0.503
AC:
68365
AN:
135782
AF XY:
0.499
show subpopulations
Gnomad AFR exome
AF:
0.685
Gnomad AMR exome
AF:
0.415
Gnomad ASJ exome
AF:
0.490
Gnomad EAS exome
AF:
0.631
Gnomad FIN exome
AF:
0.617
Gnomad NFE exome
AF:
0.513
Gnomad OTH exome
AF:
0.500
GnomAD4 exome
AF:
0.530
AC:
734459
AN:
1385566
Hom.:
197208
Cov.:
52
AF XY:
0.527
AC XY:
360833
AN XY:
684316
show subpopulations
African (AFR)
AF:
0.703
AC:
21625
AN:
30778
American (AMR)
AF:
0.426
AC:
15115
AN:
35458
Ashkenazi Jewish (ASJ)
AF:
0.494
AC:
12302
AN:
24900
East Asian (EAS)
AF:
0.640
AC:
22614
AN:
35340
South Asian (SAS)
AF:
0.431
AC:
33982
AN:
78866
European-Finnish (FIN)
AF:
0.626
AC:
25006
AN:
39952
Middle Eastern (MID)
AF:
0.481
AC:
1954
AN:
4064
European-Non Finnish (NFE)
AF:
0.529
AC:
570984
AN:
1078612
Other (OTH)
AF:
0.536
AC:
30877
AN:
57596
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
18157
36314
54471
72628
90785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16484
32968
49452
65936
82420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.586
AC:
89003
AN:
151860
Hom.:
26741
Cov.:
32
AF XY:
0.587
AC XY:
43516
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.705
AC:
29166
AN:
41382
American (AMR)
AF:
0.498
AC:
7618
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.493
AC:
1709
AN:
3468
East Asian (EAS)
AF:
0.646
AC:
3330
AN:
5154
South Asian (SAS)
AF:
0.424
AC:
2043
AN:
4816
European-Finnish (FIN)
AF:
0.651
AC:
6855
AN:
10538
Middle Eastern (MID)
AF:
0.524
AC:
154
AN:
294
European-Non Finnish (NFE)
AF:
0.538
AC:
36499
AN:
67904
Other (OTH)
AF:
0.551
AC:
1160
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1799
3598
5396
7195
8994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.545
Hom.:
56899
Bravo
AF:
0.580
ExAC
AF:
0.357
AC:
33850
Asia WGS
AF:
0.542
AC:
1874
AN:
3456

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 23, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27984487) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CASP9-related disorder Benign:1
Oct 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
15
DANN
Uncertain
1.0
DEOGEN2
Benign
0.069
.;T;.;T
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.078
N
LIST_S2
Benign
0.57
T;T;T;T
MetaRNN
Benign
0.0000057
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.7
.;L;L;.
PhyloP100
2.3
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.1
N;N;N;N
REVEL
Benign
0.0050
Sift
Benign
0.53
T;T;T;T
Sift4G
Benign
0.13
T;T;T;.
Polyphen
0.029
B;B;P;.
Vest4
0.039
MPC
0.12
ClinPred
0.021
T
GERP RS
1.3
PromoterAI
-0.028
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.35
gMVP
0.11
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1052571; hg19: chr1-15850613; COSMIC: COSV61600760; COSMIC: COSV61600760; API